# MRI in Predicting Early Response to Chemotherapy in Patients With Locally Advanced Breast Cancer

> **NCT00978770** · PHASE2 · COMPLETED · sponsor: **Cancer Clinical Trials Unit, Scotland** · enrollment: 50 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** systemic chemotherapy
- **PROCEDURE:** diffusion-weighted magnetic resonance imaging
- **PROCEDURE:** dynamic contrast-enhanced magnetic resonance imaging
- **PROCEDURE:** magnetic resonance spectroscopic imaging
- **PROCEDURE:** neoadjuvant therapy

## Key facts

- **NCT ID:** NCT00978770
- **Lead sponsor:** Cancer Clinical Trials Unit, Scotland
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** —
- **Final completion:** 2010-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2013-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00978770

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00978770, "MRI in Predicting Early Response to Chemotherapy in Patients With Locally Advanced Breast Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00978770. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*